Healios KK (HLOSF)
0.9929
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Healios Cash from Operations (TTM): -20.11M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -20.11M |
September 30, 2023 | -19.26M |
June 30, 2023 | -23.96M |
March 31, 2023 | -28.67M |
December 31, 2022 | -35.28M |
September 30, 2022 | -44.68M |
June 30, 2022 | -46.29M |
March 31, 2022 | -45.76M |
December 31, 2021 | -46.38M |
Date | Value |
---|---|
September 30, 2021 | -41.45M |
June 30, 2021 | -39.50M |
March 31, 2021 | -41.40M |
December 31, 2020 | -36.96M |
September 30, 2020 | -33.75M |
June 30, 2020 | -37.55M |
March 31, 2020 | -40.21M |
December 31, 2019 | -44.58M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-46.38M
Minimum
Dec 2021
-19.26M
Maximum
Sep 2023
-36.81M
Average
-39.50M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
Takeda Pharmaceutical Co Ltd | 5.353B |
Nxera Pharma Co Ltd | -37.58M |
PeptiDream Inc | 88.53M |
Stemcell Holdings Inc | 2.544M |
AnGes Inc | -- |